-
IntroducedApr 11, 2024
-
Passed Senate
-
Passed Assembly
-
Signed into Law
Requires health insurers to provide coverage for biomarker precision medical testing.*
Last Action See all actions
Senate • Mar 24, 2025: Substituted by A4163 (2R)
Latest Bill Text See all bill texts
Summary/Bill Text
Comments on S 3098
Tweets
Whip Lists
Sponsors
- Johnson, Gordon M.cosponsor
- Greenstein, Linda R.cosponsor
- Pennacchio, Josephcosponsor
- Diegnan, Patrick J., Jr.cosponsor
- McKnight, Angela V.cosponsor
- Beach, Jamescosponsor
- Cruz-Perez, Nilsa I.cosponsor
- Zwicker, Andrewcosponsor
- Bramnick, Jon M.cosponsor
- Burgess, Renee C.cosponsor
- Singer, Robert W.cosponsor
- Wimberly, Benjie E.cosponsor
- O'Scanlon, Declan J., Jr.cosponsor
Votes
Actions
- Mar 24, 2025 | Senate
- Substituted by A4163 (2R)
- Mar 17, 2025 | Senate
- Reported from Senate Committee with Amendments, 2nd Reading
- Dec 12, 2024 | Senate
- Reported from Senate Committee with Amendments, 2nd Reading
- Referred to Senate Budget and Appropriations Committee
- Apr 11, 2024 | Senate
- Introduced in the Senate, Referred to Senate Commerce Committee
Bill Texts
Documents
- Statement SCM 12/12/24HTML
- Statement SCM 12/12/24PDF
- Fiscal Estimate 1/10/25; 1RHTML
- Fiscal Estimate 1/10/25; 1RPDF
- Reprint SCM 12/12/24 1RHTML
- Reprint SCM 12/12/24 1RPDF
- Statement SBA 3/17/25 1RHTML
- Statement SBA 3/17/25 1RPDF
- Reprint SBA 3/17/25 2RHTML
- Reprint SBA 3/17/25 2RPDF
- Reprint SBA 3/17/25 2RHTML
- Reprint SBA 3/17/25 2RPDF
- Fiscal Estimate 3/26/25; 2RHTML
- Fiscal Estimate 3/26/25; 2RPDF